{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:35:39Z","timestamp":1754145339929,"version":"3.41.2"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013669","name":"Ionis Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jacl.2025.05.007","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T19:21:37Z","timestamp":1747768897000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of olezarsen on routinely measured lipase and amylase levels in familial chylomicronemia syndrome"],"prefix":"10.1016","author":[{"given":"Veronica J.","family":"Alexander","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1406-692X","authenticated-orcid":false,"given":"Thomas A.","family":"Prohaska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Karwatowska-Prokopczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuting","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9834-9494","authenticated-orcid":false,"given":"Sotirios","family":"Tsimikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2025.05.007_bib0001","article-title":"Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America","author":"Hegele","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2025.05.007_bib0002","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/ajg.2015.261","article-title":"Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis","volume":"110","author":"Nawaz","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacl.2025.05.007_bib0003","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa1715944","article-title":"Volanesorsen and triglyceride levels in familial chylomicronemia syndrome","volume":"381","author":"Witztum","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2025.05.007_bib0004","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa2400201","article-title":"Olezarsen, acute pancreatitis, and familial chylomicronemia syndrome","volume":"390","author":"Stroes","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2025.05.007_bib0005","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1056\/NEJMoa2409368","article-title":"Plozasiran for managing persistent chylomicronemia and pancreatitis risk","volume":"392","author":"Watts","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2025.05.007_bib0006","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","article-title":"Classification of acute pancreatitis\u20132012: revision of the Atlanta classification and definitions by international consensus","volume":"62","author":"Banks","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jacl.2025.05.007_bib0007","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jacl.2017.04.043","article-title":"Natural history (up to 15 years) of platelet count in 84 patients with familial hyperchylomicronemia due to lipoprotein lipase deficiency","volume":"11","author":"Gaudet","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2025.05.007_bib0008","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacl.2018.03.093","article-title":"Clinical and biochemical features of different molecular etiologies of familial chylomicronemia","volume":"12","author":"Hegele","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2025.05.007_bib0009","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1056\/NEJMoa1715944","article-title":"Familial chylomicronemia syndrome, and thrombocytopenia. Reply","volume":"381","author":"Witztum","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jacl.2025.05.007_bib0010","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jacl.2018.04.009","article-title":"The burden of familial chylomicronemia syndrome: results from the global IN-FOCUS study","volume":"12","author":"Davidson","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2025.05.007_bib0011","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","article-title":"Targeting APOC3 in the familial chylomicronemia syndrome","volume":"371","author":"Gaudet","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2025.05.007_bib0012","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMc2306575","article-title":"Volanesorsen to prevent acute pancreatitis in hypertriglyceridemia","volume":"390","author":"Alexander","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2025.05.007_bib0013","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/ajcp\/96.5.610","article-title":"Lipase and pancreatic amylase activities in tissues and in patients with hyperamylasemia","volume":"96","author":"Apple","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jacl.2025.05.007_bib0014","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00006676-199801000-00008","article-title":"A comparison of lipase and amylase in the diagnosis of acute pancreatitis in patients with abdominal pain","volume":"16","author":"Keim","year":"1998","journal-title":"Pancreas"},{"key":"10.1016\/j.jacl.2025.05.007_bib0015","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1572-0241.2002.05766.x","article-title":"A critical evaluation of laboratory tests in acute pancreatitis","volume":"97","author":"Yadav","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacl.2025.05.007_bib0016","article-title":"Genetic determinants of pancreatitis risk in hypertriglyceridemia","author":"Paquette","year":"2024","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.jacl.2025.05.007_bib0017","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1016\/j.jacl.2024.02.007","article-title":"Pancreatitis polygenic risk score is associated with acute pancreatitis in multifactorial chylomicronemia syndrome","volume":"18","author":"Guay","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacl.2025.05.007_bib0018","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.clinbiochem.2017.07.003","article-title":"Lipase or amylase for the diagnosis of acute pancreatitis?","volume":"50","author":"Ismail","year":"2017","journal-title":"Clin Biochem"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425002880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425002880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T20:58:14Z","timestamp":1752699494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425002880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":18,"alternative-id":["S1933287425002880"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.05.007","relation":{},"ISSN":["1933-2874"],"issn-type":[{"type":"print","value":"1933-2874"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of olezarsen on routinely measured lipase and amylase levels in familial chylomicronemia syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}